These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9017795)

  • 21. Porphyria cutanea tarda: a case report.
    Usta Atmaca H; Akbas F
    J Med Case Rep; 2019 Jan; 13(1):17. PubMed ID: 30661508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Porphyria cutanea tarda accompanying hepatitis C].
    Yamazaki Y; Kiyosawa K
    Nihon Rinsho; 1995 Jun; 53(6):1468-73. PubMed ID: 7542354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of uroporphyrinogen decarboxylase (URO-D) in erythrocytes of Italian porphyria cutanea tarda patients.
    Tavazzi D; Martinez di Montemuros F; Fargion S; Fracanzani AL; Fiorelli G; Cappellini MD
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):27-32. PubMed ID: 11929044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
    Held JL; Sassa S; Kappas A; Harber LC
    J Invest Dermatol; 1989 Sep; 93(3):332-4. PubMed ID: 2768832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal coproporphyrin isomers in sporadic and familial porphyria cutanea tarda.
    Badcock NR; Szep DA; Zoanetti GD; Lewis BD
    Clin Chem; 1995 Sep; 41(9):1315-7. PubMed ID: 7656445
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives.
    Badenas C; To-Figueras J; Phillips JD; Warby CA; Muñoz C; Herrero C
    Clin Genet; 2009 Apr; 75(4):346-53. PubMed ID: 19419417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of familial porphyria cutanea tarda.
    Roberts AG; Elder GH; Newcombe RG; Enriquez de Salamanca R; Munoz JJ
    J Med Genet; 1988 Oct; 25(10):669-76. PubMed ID: 3225822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Porphyria cutanea tarda and hepatoerythropoietic porphyria].
    Nonaka S; Takamiyagi A
    Nihon Rinsho; 1995 Jun; 53(6):1427-32. PubMed ID: 7616658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
    Egger NG; Goeger DE; Payne DA; Miskovsky EP; Weinman SA; Anderson KE
    Dig Dis Sci; 2002 Feb; 47(2):419-26. PubMed ID: 11855561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
    Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
    Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porphyria cutanea tarda.
    Bleasel NR; Varigos GA
    Australas J Dermatol; 2000 Nov; 41(4):197-206; quiz 207-8. PubMed ID: 11105361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population.
    Méndez M; Rossetti MV; Del C Batlle AM; Parera VE
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):417-24. PubMed ID: 15761419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. Mutation in brief no. 237. Online.
    McManus JF; Begley CG; Sassa S; Ratnaike S
    Hum Mutat; 1999; 13(5):412. PubMed ID: 10338097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage.
    Lederhandler M; Chen L; Meehan SA; Brinster NK; Neimann A
    Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda.
    Kószó F; Morvay M; Dobozy A; Simon N
    Br J Dermatol; 1992 May; 126(5):446-9. PubMed ID: 1610684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.